ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 60 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $639 | – | 60 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 60 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 60 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 60 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $1,000 | – | 60 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 60 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 60 | -71.4% | 0.00% | -100.0% |
| Q4 2020 | $1,000 | – | 210 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Intrepid Financial Planning Group LLC | 18,000 | $106,560 | 0.06% |
| PERRITT CAPITAL MANAGEMENT INC | 12,000 | $71,040 | 0.04% |
| CREATIVE FINANCIAL DESIGNS INC /ADV | 16,625 | $98,420 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 63,966 | $378,679 | 0.01% |
| Brandywine Global Investment Management, LLC | 174,500 | $1,033,040 | 0.01% |
| J. Goldman & Co LP | 13,500 | $79,920 | 0.00% |
| ROYCE & ASSOCIATES LP | 50,000 | $296,000 | 0.00% |
| Retirement Group, LLC | 1,191 | $7,051 | 0.00% |
| B. Riley Wealth Advisors, Inc. | 14,550 | $86,136 | 0.00% |
| Hartford Financial Management Inc. | 598 | $3,541 | 0.00% |